Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
CA 2487414 A1 · Owner: Garvey, David S. · Inventors: Garvey, David S.; Letts, L. Gordon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention describes novel nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) selective inhibitor and, optionally, at least one compound that donates transfers or releases , nitric oxide, stimulates endogenous synthesis of nitric oxide elevates , endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or, optionally at least one therapeutic agent. The , invention also provides novel compositions comprising at least one COX-2 selective inhibitor, that is optionally sitrosated and/or nitrosylated and, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.